Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 15801 - 15825 of 16010 in total
Nitarsone is an organoarsenic compound. It is used as an additive in poultry feed to improve weight gain and feed efficiency, while preventing blackhead disease. It is marketed as Histostat by Zoetis, a publicly traded subsidiary of Pfizer.
Vet approved
Matched Description: … It is used as an additive in poultry feed to improve weight gain and feed efficiency, while preventing …
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Investigational
Get 73 has been investigated for the treatment of Alcohol Dependence.
Investigational
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
TAK-428 is a drug for treating diabetic neuropathy. It is based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and regenerated by stimulating an increase in neurotrophic factors.
Investigational
Matched Description: … based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and
Phenoxypropazine is a non-selective and irreversible monoamine oxidase enzyme inhibitor (MAOI), belonging to the hydrazine chemical class. It was marketed as an antidepressant in 1961 but was later withdrawn in 1966 because of its hepatotoxic potential.
Withdrawn
Matched Description: … Phenoxypropazine is a non-selective and irreversible monoamine oxidase enzyme inhibitor (MAOI), belonging …
Experimental
Experimental
Netoglitazone (MCC-555) is a hypoglycemic agent.
Experimental
Zotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma).
Investigational
Matched Description: … (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Investigational
Displaying drugs 15801 - 15825 of 16010 in total